Aromatase inhibitor
Drug timelines are a Plus or Pro feature.
25 regulatory and trial events tracked for Aromatase inhibitor, covering 2007-04-23 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer [Phase 1]